A Comparative Evaluation Of Propofol Versus Dexmedetomidine Effects On Haemodynamic Responses, Seizure Duration And Recovery Profile Following Electroconvulsive Therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202402621085427

Enrollment

Registered

2024-02-05

Start date

2024-02-18

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental and Behavioural Disorders Anaesthesia

Interventions

PROPOFOL

dexmedetomidine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age 18 years and above. 2. Patients with American Society of Anesthesiologists (ASA) physical status class I or II.

Exclusion criteria

Exclusion criteria: 1. Refusal of Patient or guardian to give written informed consent. 2. Age below 18 years. 3. Patient with ASA > II 4. History of allergy or sensitivity to the study medications. 5. Presence or evidence of raised intracranial pressure. 6. Presence of glaucoma 7. Present or recent myocardial infarction (by history or ECG, lab results). 8. Anticipated difficult airway 9. Systemic hypertension

Design outcomes

Primary

Measure	Time frame
Mean arterial pressure changes at 1 min	—

Secondary

Measure	Time frame
1. Haemodynamic changes at 1 min, 5 min, 10 min and 20 min. 2. Seizure duration 3. Recovery time 4. Post-ECT pain score using Pain Assessment in Advanced Dementia (PAINAD) scale	—

Countries

Nigeria

Contacts

Public ContactChristian Igibah

Research Assistant

igibah@cancad.org+2347059126266

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026